Treatment of patients with chronic hepatitis C and normal ALT levels

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 193-196

  Tassopoulos, Nicholas C ^a  

^a Western Attica General Hospital   (Greece)

Author keywords

Chronic hepatitis C; Interferon alpha; Normal aminotransferase level; Response rates

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0033431808     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80400-0     Document Type: Conference Paper

References (21)

1. Me Quillan GM, Alter MJ, Moyer LA, Lambert SB, Margolis HS. A population based sérologie study of hepatitis C virus infection in the United States. In: Rizetto M, Purcell RH, Gerin JL, Verme G, editors. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica: 1997. p. 267-270.
2. Gholson CF, Morgan K, Catinis G, Favrot D, Taylor B, Gonzalez E et al. Chronic hepatitis C with normal aminotransferase levels. A clinical histologie study. Am J Gastroenterol 1997: 92: 17881792.
3. Shakil AO, Conry-Cantelina C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologie and histologie features. Ann Intern Med 1995: 123: 330-337.
4. Serfaty L, Chazouillieres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alpha therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996: 110: 291-295.
5. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M et al. Does the healthy hepatitis C virus carriers state really exist? An analysis using polymerase chain reaction. Hepatology 1995: 22:413-417.
6. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991: 115:443-149.
7. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus positive subjects with normal liver biochemical values. Hepatology 1995: 22: 418-425.
8. McGuiness PH, Bishop GA, Lien A, Wiley B, Parsons C, McCaughan GW. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993: 18: 485-490.
9. Healey CJ, Chapmann RWG, Fleming, K. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminase. Gut 1995: 37: 274-278.
10. Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995: 15: 514.
11. Marcellin, P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology 1997: 26 (SuppI 1): 133S-136S.
12. Rossini A, Ravaggi A, Biasi L, Agostinelli E, Bereich L, Gazzola GB et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997: 26: 1012-1017.
13. Ideo G, Bellobuono A, Temprini S, Mondazzi L, Bellati G, Zanetti AR. Poor efficacy of alpha-interferon treatment in patients affected by chronic hepatitis C with normal or near normal ALT levels. Gastroenterology 1996: 110: 1215A.
14. Sangiovanni A, Morales R, Spinzi G, Rumi MG, Casiraghi A, Ceriani R, et al. Interferon alpha treatment of HCVRNA carriers with persistently normal transamiminase levels: a pilot randomized controlled study. Hepatology 1998: 27: 853-856.
15. Areias J, Pedroto I, Freitas T, Cerqueira R, Teixeira R, Pinho I et al. Hepatitis C virus carriers with normal ALT activity: viremia, genotype and effect of interferon therapy. Gastroenterology 1996: 110: 1144A.
16. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mizuno M et al. Interferon alpha therapy for individuals with normal serum ALT before treatment. J Gastroenterol Hepatol 1996: 12: 58-61.
17. VanThiel D, Caraceni P, Molloy PJ, Hassanein T, Kania RJ, Gurakar A et al. Chronic hepatitis C in patients with normal or near normal ALT levels. J Hepatol 1995: 23: 503-508.
18. Nordoy I, Krarup HB, Bell IV, Christensen PB, Elgjo B, von der Lippe B et al. Interferon-2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol 1997: 32: 1256-1260.
19. Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC. Alpha-interferon treatment of HCVRNA - positive patients with normal or near-normal ALT levels. Am J Gastroenterol 1997:92: 1793-1795.
20. Baron S, Tyring SK, Fleischmann WR Jr, Coppenhauer DH, Niesel DW, Kumpel OR. The interferons: mechanisms of action and clinical applications. JAMA 1991: 266: 1375-1383.
21. Longo F, Tran A, Dantin S et al. Virological and histological effects of interferon treatment in HCV positive patients with persistently normal ALT levels. Hepatology 1998: 28: 705A.